What are the benefits of targeted therapy for advanced and metastatic lung cancer?

Lung cancer is a common malignant tumor of the respiratory system, with biological characteristics of invasion, growth and metastasis. It can be transferred to different parts through blood circulation, Ba circulation, etc., including liver, lung, bone and other parts, and the corresponding symptoms of the metastasis site can appear. The prognosis of advanced lung cancer is poor, and most of them have no indication for surgery.

If constitution allows, radiotherapy, chemotherapy, and targeted drugs** may be considered to slow tumor progression. Genetic testing is required for the suitability of targeted drugs**.

Hydrophilism caused by lung cancer is a common complication of cancer. The primary lesion should be actively sought, **the primary tumor. If the primary tumor can**, the fluid will resolve or disappear.

If the effusion causes symptoms, fluid aspiration and drainage should be performed to relieve symptoms, and intraluminal infusion of local drugs should be performed. It is recommended to cooperate with Chinese medicine practitioners**. Targeted drugs are a new tumor method, which has the characteristics of relatively less toxicity.

According to the pathological type of the tumor and individual differences, the first means are decided. It is best to detect the susceptibility gene of the targeted drug, and the gene mutation can be selected.

Targeted** for advanced lung cancer is effective and similar to chemotherapy. However, its advantage is that for patients with advanced tumors, even if chemotherapy is ineffective, or chemotherapy is ineffective, and their own constitution is poor, it can achieve better ** results, and can improve the disease control rate to a greater extent than chemotherapy. However, some cancer patients have poor tolerance to targeted drugs, and specific methods should be selected according to the specific conditions of the disease and personal physical factors.

To sum up, through genetic testing, finding the corresponding target is not only effective, but also much smaller and has a higher quality of life compared with radiotherapy, chemotherapy and intervention. However, there are many limitations to use, i.e., lung cancer is prone to developing resistance to targeted drugs. The use of other drugs can effectively improve the resistance of targeted drugs, improve the first effect, shorten the first cycle, and reduce the pain of patients.

Long-term use can also enhance the body's immunity and provide physical support for patients who are **.

It can control the metastasis of cancer cells in time, and it may also shrink the tumor after taking it, but this drug is relatively expensive, and you should choose to buy it according to your financial ability.

It can alleviate the symptoms, will not produce *** to the body, the effect is relatively good, can help stabilize the condition, and can achieve the best ** effect.

Being able to accurately determine the location of the lesion, stabilize the condition, soothe the patient's mood, reduce the patient's pain, and improve the probability of **, these are all benefits.

Very few patients with terminal cancer can do it**This is an indisputable fact. At this stage of treatment, if the effect is good, the tumor cells can be controlled for a long time; However, a large number of patients, even with the most modern treatments, are likely to only manipulate tumor cells for a short period of time, and later treatment will be ineffective, and many patients will survive for no more than 5 years. Moreover, the cost of this kind of excellent treatment is very high, and many of them are not covered by medical insurance reimbursement and <>

The first consideration is basic medical treatment, or targeted drugs that have been covered by medical insurance**, etc. For the basic treatment of middle and advanced malignant tumors, mainly chemoradiotherapy and palliative chemoradiotherapy, etc., for this kind of treatment, the relevant data statistics are relatively large, and the mean effective time of this treatment can be clearly grasped, the relevant adverse reactions, etc., if the high efficiency is high, the adverse reaction patients can bear, then it should be selected. This kind of treatment is usually reimbursable for medical treatment, and the cost is generally controllable, usually in the tens of thousands.

If the health is already very poor, the patient may not be able to withstand radiotherapy and chemotherapy, or the economic development standard is really limited, or there is no medical insurance, then this treatment can be dispensed with and the pain-reducing palliative treatment can be adopted. The second is the targeted ** drug that has been included in the medical insurance, which is very likely to be reasonable for most patients (only the time period of manipulation of the condition has a length of time), and since 2017, it has been included in the medical insurance reimbursement, with a monthly cost of 1-2000 yuan, and most patients can basically accept it. Adverse reactions also occur with natural targeted ** drugs, and if the adverse reactions are uncontrollable or unbearable with the application of targeted ** drugs, then they should be discontinued.

We must attach great importance to scientific and reasonable recovery methods, clinical medicine at this stage of the comprehensive effect of Chinese and Western medicine or very good, not only can stimulate the deep clean-up of diseases in Western medicine, but also can stimulate the strong muscles and bones of traditional Chinese medicine, improve the body's resistance, reduce adverse reactions, improve the quality of survival, reasonably increase the patient's life, and the cost will not be very high. The adverse reactions of each targeted drug are different, and before the application of targeted drugs, you should fully understand what the targeted drugs you are using, and how to measure the range. Once the third degree is achieved, the use of drugs must be stopped to solve the problem

I think it is still very necessary for patients with advanced cancer to receive targeted **; The normal cycle of targeting ** is about one month, but each person's physique is different and not fixed.

It is also necessary for patients with advanced cancer to receive targeting, and advanced cancer does not mean the end of life. The cycle of targeting ** is generally decided according to each course of treatment, and if ** is effective, long-term medication is required.

I think it's also necessary, then we should also be positive about our lives, we must have an optimistic attitude, and its cycle is generally about two or three months.

Ask the doctor, after the method is determined, the patient himself must actively cooperate, and if the family has financial difficulties, they can easily raise money to initiate a request for help, which is quite a reliable platform, as far as I know, there are many people who get help through this.

Targeting** is not suitable for everyone, check it first, if you can do targeting**, the doctor will prescribe medicine for you! Do you still need to check it yourself? You can take a look at the case of a better recovery.

Liu also perseveres to the end on the journey of cancer", which is a very good example.

Targeting refers to the method in which the drug targets the specific target of the tumor. It has good efficacy and milder side effects. The premise of targeting ** is that there is a target in the tumor, and the technical term is called genetic abnormality, such as gene mutation, rearrangement, amplification, etc.

Common ** targets are EGFR, ALK, ROS1, MET, RET, BRAF, HER2, etc.

How to know if there is a target in the tumor, genetic testing is done. Tumor tissue is first obtained by biopsy, and then genetic testing is performed on the tumor tissue. There are two important time points for genetic testing, one is that patients should do genetic testing at the time of their first diagnosis, so that they can know whether there is a target and whether it is suitable for targeting**.

The second is that after the patient is targeted, when drug resistance occurs, a biopsy is done, and genetic testing is done to clarify which is the cause of drug resistance, so as to choose a more appropriate **, so the second biopsy is also very important. Targeting** is also the main embodiment of precision diagnosis and treatment. Targeting** is well established in NSCLC patients, so genetic testing is also targeting NSCLC.

Generally, the results of targeted genetic testing are based.

Choose the right one.

India is more comprehensive and the lowest.

Refer to Centakang Pharmaceutical.

Drunk Penglai: According to "The Conversation of Mishui Yan", when Song Renzong was in power, the new song "Drunk Penglai" was taught by the workshop, and Liu Yongying made the lyrics. Ninety-seven characters in two tones, four rhymes before and after the film. The first film.

I. Fifth, the eighth and third sentences, the second film.

Sixth, the ninth two sentences, both above.

1. The next four syntax.

Ancient Mountain: refers to Huiji Mountain, the hometown of Wang Yisun.

Sweeping the West Wind Doorway: The first sentence is upside down, which means "the west wind sweeps the doorway".

Willow for withered shade: refers to the willow leaves withered through autumn.

Fu returns: resign and return to his hometown. Tao Yuanming's "Words of Return": "When you return, the countryside will not return." ”

爽气霏霏霏 (fēi): The mountains are filled with fresh air, and the words of "The World Speaks New Language: Jian Ao": "The West Mountain is coming, and there is a refreshing air". Feifei: Successively.

Emerald moth eyebrows: Describe the verdant distant mountains like the eyebrows of beautiful women.

The old country is like dust: It refers to the ashes of the Song dynasty in the old country.

Hanying: Chrysanthemums.

Chu Lu is difficult to recruit: "Chu Ci" has an article on summoning spirits, which is generally believed to be written by Qu Yuan to recruit King Chu Huai to return.

步屧 (xiè): to stroll. Slippers.

Elimination: Elimination, dissolution.

In view of the patient's condition, multicellular targeting** may be considered.

Genetic testing is required before lung cancer is targeted**. During the period of taking targeted drugs, it is recommended to take them together with traditional Chinese medicine, which can reduce *** and prolong drug resistance.

With the help of the continuous progress of modern scientific and technological means, people's understanding of tumors has penetrated to the cellular, molecular and genetic levels, and the mastery of tumor diagnosis and technology has no longer stayed at the level of site and organ morphology, but combined with morphological and functional changes, and gradually developed in the direction of cytology, molecular biology and even genomics classification diagnosis and development.